Zacks Small Cap Research on MSN21 小时
AEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating ...
AEMD READ THE FULL AEMD RESEARCH REPORT Patient treatments begin in AEMD’s basket oncology trial, enrollments expected to accelerate Aethlon Medical (NASDAQ:AEMD) reported FY 3Q results yesterday and ...
MassDevice16 小时
Outset Medical resolves FDA warning letter
Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.